LaSalle Street Capital Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $211K | Hold |
1,592
| – | – | 0.24% | 85 |
|
|
2019
Q2 | $226K | Hold |
1,592
| – | – | 0.26% | 83 |
|
|
2019
Q1 | $231K | Sell |
1,592
-1,130
| -42% | -$164K | 0.27% | 84 |
|
|
2018
Q4 | $308K | Sell |
2,722
-1,367
| -33% | -$155K | 0.44% | 71 |
|
|
2018
Q3 | $550K | Sell |
4,089
-26
| -0.6% | -$3.5K | 0.64% | 55 |
|
|
2018
Q2 | $462K | Sell |
4,115
-1,824
| -31% | -$205K | 0.46% | 67 |
|
|
2018
Q1 | $634K | Sell |
5,939
-274
| -4% | -$29.3K | 0.5% | 67 |
|
|
2017
Q4 | $680K | Buy |
6,213
+894
| +17% | +$97.8K | 0.47% | 65 |
|
|
2017
Q3 | $575K | Buy |
5,319
+944
| +22% | +$102K | 0.42% | 66 |
|
|
2017
Q2 | $443K | Hold |
4,375
| – | – | 0.36% | 62 |
|
|
2017
Q1 | $394K | Hold |
4,375
| – | – | 0.33% | 65 |
|
|
2016
Q4 | $333K | Buy |
4,375
+1,763
| +67% | +$134K | 0.3% | 65 |
|
|
2016
Q3 | $218K | Hold |
2,612
| – | – | 0.2% | 82 |
|
|
2016
Q2 | $215K | Buy |
+2,612
| New | +$215K | 0.21% | 80 |
|
|
2016
Q1 | – | Sell |
-2,644
| Closed | -$213K | – | 84 |
|
|
2015
Q4 | $213K | Buy |
+2,644
| New | +$213K | 0.21% | 76 |
|